|
|
Blood, 15 October 2007, Vol. 110, No. 8, pp. 2983-2990.
Prepublished online as a Blood First Edition Paper on July 20, 2007; DOI 10.1182/blood-2007-06-094656.
Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
Induction of FOXP3 expression in naive human CD4+FOXP3– T cells by T-cell receptor stimulation is transforming growth factor-ß–dependent but does not confer a regulatory phenotype
Dat Q. Tran1,
Heather Ramsey1, and
Ethan M. Shevach1
1 Laboratory of Immunology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD
Thymic-derived natural T-regulatory cells (nTregs) are important for the induction of self-tolerance and the control of autoimmunity. Murine CD4+CD25–Foxp3– cells can be induced to express Foxp3 after T-cell receptor (TCR) activation in the presence of transforming growth factor ß (TGFß) and are phenotypically similar to nTregs. Some studies have suggested that TCR stimulation of human CD4+CD25– cells results in the induction of transient expression of FOXP3, but that the induced cells lack a regulatory phenotype. We demonstrate here that TCR stimulation alone was insufficient to induce FOXP3 expression in the absence of TGFß, whereas high levels of FOXP3 expression could be induced in the presence of TGFß. Although FOXP3 expression was stable, the TGFß-induced FOXP3+ T cells were neither anergic nor suppressive and produced high levels of effector cytokines. These results suggest that even high levels of FOXP3 expression are insufficient to define a human CD4+ T cell as a T-regulatory cell.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Articles in Blood Online:
-
Defense of the clone: antibody 259D effectively labels human FOXP3 in a variety of applications
- Bridget C. Fox, Paola A. Bignone, Philip J. Brown, and Alison H. Banham
Blood 2008 111: 3897-3899.
[Full Text]
[PDF]
-
Attack on the clones? Human FOXP3 detection by PCH101, 236A/E7, 206D, and 259D reveals 259D as the outlier with lower sensitivity
- Vinodh Pillai and Nitin J. Karandikar
Blood 2008 111: 463-464.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
P. Nigam, V. Velu, S. Kannanganat, L. Chennareddi, S. Kwa, M. Siddiqui, and R. R. Amara
Expansion of FOXP3+ CD8 T Cells with Suppressive Potential in Colorectal Mucosa Following a Pathogenic Simian Immunodeficiency Virus Infection Correlates with Diminished Antiviral T Cell Response and Viral Control
J. Immunol.,
February 15, 2010;
184(4):
1690 - 1701.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Chen and J. E. Konkel
TGF-{beta} and 'Adaptive' Foxp3+ Regulatory T cells
J Mol Cell Biol,
February 1, 2010;
2(1):
30 - 36.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Raimondi, T. L. Sumpter, B. M. Matta, M. Pillai, N. Corbitt, Y. Vodovotz, Z. Wang, and A. W. Thomson
Mammalian Target of Rapamycin Inhibition and Alloantigen-Specific Regulatory T Cells Synergize To Promote Long-Term Graft Survival in Immunocompetent Recipients
J. Immunol.,
January 15, 2010;
184(2):
624 - 636.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Benito-Miguel, Y. Garcia-Carmona, A. Balsa, C. Perez de Ayala, T. Cobo-Ibanez, E. Martin-Mola, and M.-E. Miranda-Carus
A Dual Action of Rheumatoid Arthritis Synovial Fibroblast IL-15 Expression on the Equilibrium between CD4+CD25+ Regulatory T Cells and CD4+CD25- Responder T Cells
J. Immunol.,
December 15, 2009;
183(12):
8268 - 8279.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Yessoufou, A. Ple, K. Moutairou, A. Hichami, and N. A. Khan
Docosahexaenoic acid reduces suppressive and migratory functions of CD4CD25 regulatory T-cells
J. Lipid Res.,
December 1, 2009;
50(12):
2377 - 2388.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. E. Jeffery, F. Burke, M. Mura, Y. Zheng, O. S. Qureshi, M. Hewison, L. S. K. Walker, D. A. Lammas, K. Raza, and D. M. Sansom
1,25-Dihydroxyvitamin D3 and IL-2 Combine to Inhibit T Cell Production of Inflammatory Cytokines and Promote Development of Regulatory T Cells Expressing CTLA-4 and FoxP3
J. Immunol.,
November 1, 2009;
183(9):
5458 - 5467.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Bernard, K. E. Seweryniak, A. D. Koniski, S. L. Spinelli, N. Blumberg, C. W. Francis, M. B. Taubman, J. Palis, and R. P. Phipps
Foxp3 Regulates Megakaryopoiesis and Platelet Function
Arterioscler Thromb Vasc Biol,
November 1, 2009;
29(11):
1874 - 1882.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Lal and J. S. Bromberg
Epigenetic mechanisms of regulation of Foxp3 expression
Blood,
October 29, 2009;
114(18):
3727 - 3735.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Jurgens, U. Hainz, D. Fuchs, T. Felzmann, and A. Heitger
Interferon-{gamma}-triggered indoleamine 2,3-dioxygenase competence in human monocyte-derived dendritic cells induces regulatory activity in allogeneic T cells
Blood,
October 8, 2009;
114(15):
3235 - 3243.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Pozo, P. Anderson, and E. Gonzalez-Rey
Induction of Alloantigen-Specific Human T Regulatory Cells by Vasoactive Intestinal Peptide
J. Immunol.,
October 1, 2009;
183(7):
4346 - 4359.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. C. Chen, J. C. Delgado, P. E. Jensen, and X. Chen
Direct Expansion of Human Allospecific FoxP3+CD4+ Regulatory T Cells with Allogeneic B Cells for Therapeutic Application
J. Immunol.,
September 15, 2009;
183(6):
4094 - 4102.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wang, T. W. J. Huizinga, and R. E. M. Toes
De Novo Generation and Enhanced Suppression of Human CD4+CD25+ Regulatory T Cells by Retinoic Acid
J. Immunol.,
September 15, 2009;
183(6):
4119 - 4126.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. OLIVITO, G. SIMONINI, S. CIULLINI, M. MORIONDO, L. BETTI, E. GAMBINERI, L. CANTARINI, M. DE MARTINO, C. AZZARI, and R. CIMAZ
Th17 Transcription Factor RORC2 Is Inversely Correlated with FOXP3 Expression in the Joints of Children with Juvenile Idiopathic Arthritis
J Rheumatol,
September 1, 2009;
36(9):
2017 - 2024.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Q. Tran, J. Andersson, R. Wang, H. Ramsey, D. Unutmaz, and E. M. Shevach
GARP (LRRC32) is essential for the surface expression of latent TGF-{beta} on platelets and activated FOXP3+ regulatory T cells
PNAS,
August 11, 2009;
106(32):
13445 - 13450.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Wang, L. Kozhaya, F. Mercer, A. Khaitan, H. Fujii, and D. Unutmaz
Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells
PNAS,
August 11, 2009;
106(32):
13439 - 13444.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Luther, E. Adamopoulou, C. Stoeckle, V. Brucklacher-Waldert, D. Rosenkranz, L. Stoltze, S. Lauer, S. Poeschel, A. Melms, and E. Tolosa
Prednisolone Treatment Induces Tolerogenic Dendritic Cells and a Regulatory Milieu in Myasthenia Gravis Patients
J. Immunol.,
July 15, 2009;
183(2):
841 - 848.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Billerbeck, N. Nakamoto, B. Seigel, H. E. Blum, K.-M. Chang, and R. Thimme
Determinants of in vitro expansion of different human virus-specific FoxP3+ regulatory CD8+ T cells in chronic hepatitis C virus infection
J. Gen. Virol.,
July 1, 2009;
90(7):
1692 - 1701.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Matthews, Z. Lim, B. Afzali, L. Pearce, A. Abdallah, S. Kordasti, A. Pagliuca, G. Lombardi, J. A. Madrigal, G. J. Mufti, et al.
Imbalance of effector and regulatory CD4 T cells is associated with graft-versus-host disease after hematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab
Haematologica,
July 1, 2009;
94(7):
956 - 966.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. B. L. Pillemer, Z. Qi, B. Melgert, T. B. Oriss, P. Ray, and A. Ray
STAT6 Activation Confers upon T Helper Cells Resistance to Suppression by Regulatory T Cells
J. Immunol.,
July 1, 2009;
183(1):
155 - 163.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Nagata, T. Ise, and I. Pastan
Fc Receptor-Like 3 Protein Expressed on IL-2 Nonresponsive Subset of Human Regulatory T Cells
J. Immunol.,
June 15, 2009;
182(12):
7518 - 7526.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Takahashi, Y. Kano, Y. Yamazaki, M. Kimishima, Y. Mizukawa, and T. Shiohara
Defective Regulatory T Cells In Patients with Severe Drug Eruptions: Timing of the Dysfunction Is Associated with the Pathological Phenotype and Outcome
J. Immunol.,
June 15, 2009;
182(12):
8071 - 8079.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. B. Ahmed, N. Belhadj Hmida, N. Moes, S. Buyse, M. Abdeladhim, H. Louzir, and N. Cerf-Bensussan
IL-15 Renders Conventional Lymphocytes Resistant to Suppressive Functions of Regulatory T Cells through Activation of the Phosphatidylinositol 3-Kinase Pathway
J. Immunol.,
June 1, 2009;
182(11):
6763 - 6770.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ayyoub, F. Deknuydt, I. Raimbaud, C. Dousset, L. Leveque, G. Bioley, and D. Valmori
Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the TH17 lineage-specific transcription factor ROR{gamma}t
PNAS,
May 26, 2009;
106(21):
8635 - 8640.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Q. Tran, J. Andersson, D. Hardwick, L. Bebris, G. G. Illei, and E. M. Shevach
Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I/II (CD121a/CD121b) on activated human FOXP3+ regulatory T cells allows for their purification from expansion cultures
Blood,
May 21, 2009;
113(21):
5125 - 5133.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bosco, K. L. McKenna, M. J. Firth, P. D. Sly, and P. G. Holt
A Network Modeling Approach to Analysis of the Th2 Memory Responses Underlying Human Atopic Disease
J. Immunol.,
May 15, 2009;
182(10):
6011 - 6021.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Francois, S. Ottaviani, N. Renkvist, J. Stockis, G. Schuler, K. Thielemans, D. Colau, M. Marchand, T. Boon, S. Lucas, et al.
The CD4+ T-Cell Response of Melanoma Patients to a MAGE-A3 Peptide Vaccine Involves Potential Regulatory T Cells
Cancer Res.,
May 15, 2009;
69(10):
4335 - 4345.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Kryczek, R. Liu, G. Wang, K. Wu, X. Shu, W. Szeliga, L. Vatan, E. Finlayson, E. Huang, D. Simeone, et al.
FOXP3 Defines Regulatory T Cells in Human Tumor and Autoimmune Disease
Cancer Res.,
May 1, 2009;
69(9):
3995 - 4000.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Beriou, C. M. Costantino, C. W. Ashley, L. Yang, V. K. Kuchroo, C. Baecher-Allan, and D. A. Hafler
IL-17-producing human peripheral regulatory T cells retain suppressive function
Blood,
April 30, 2009;
113(18):
4240 - 4249.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-L. Zhang, J. Peng, J.-Z. Sun, J.-J. Liu, C.-S. Guo, Z.-G. Wang, Y. Yu, Y. Shi, P. Qin, S.-G. Li, et al.
De novo induction of platelet-specific CD4+CD25+ regulatory T cells from CD4+CD25- cells in patients with idiopathic thrombocytopenic purpura
Blood,
March 12, 2009;
113(11):
2568 - 2577.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. W. Mailloux and M. R. I. Young
NK-Dependent Increases in CCL22 Secretion Selectively Recruits Regulatory T Cells to the Tumor Microenvironment
J. Immunol.,
March 1, 2009;
182(5):
2753 - 2765.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. F. de Zoeten, I. Lee, L. Wang, C. Chen, G. Ge, A. D. Wells, W. W. Hancock, and E. Ozkaynak
Foxp3 Processing by Proprotein Convertases and Control of Regulatory T Cell Function
J. Biol. Chem.,
February 27, 2009;
284(9):
5709 - 5716.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. H. Kim, B. K. Choi, H. S. Oh, W. J. Kang, R. S. Mittler, and B. S. Kwon
Mechanisms involved in synergistic anticancer effects of anti-4-1BB and cyclophosphamide therapy
Mol. Cancer Ther.,
February 1, 2009;
8(2):
469 - 478.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kleinewietfeld, M. Starke, D. Di Mitri, G. Borsellino, L. Battistini, O. Rotzschke, and K. Falk
CD49d provides access to "untouched" human Foxp3+ Treg free of contaminating effector cells
Blood,
January 22, 2009;
113(4):
827 - 836.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Lal, N. Zhang, W. van der Touw, Y. Ding, W. Ju, E. P. Bottinger, St. P. Reid, D. E. Levy, and J. S. Bromberg
Epigenetic Regulation of Foxp3 Expression in Regulatory T Cells by DNA Methylation
J. Immunol.,
January 1, 2009;
182(1):
259 - 273.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Game, X. Cao, and S. Jiang
Regulatory T Cells: The Cunning Fox and Its Clinical Application
Sci. Signal.,
December 23, 2008;
1(51):
mr3 - mr3.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Vogtenhuber, M. J. O'Shaughnessy, D. A. A. Vignali, and B. R. Blazar
Outgrowth of CD4low/negCD25+ T Cells with Suppressor Function in CD4+CD25+ T Cell Cultures upon Polyclonal Stimulation Ex Vivo
J. Immunol.,
December 15, 2008;
181(12):
8767 - 8775.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Flores-Borja, E. C. Jury, C. Mauri, and M. R. Ehrenstein
Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis
PNAS,
December 9, 2008;
105(49):
19396 - 19401.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Bardel, F. Larousserie, P. Charlot-Rabiega, A. Coulomb-L'Hermine, and O. Devergne
Human CD4+CD25+Foxp3+ Regulatory T Cells Do Not Constitutively Express IL-35
J. Immunol.,
November 15, 2008;
181(10):
6898 - 6905.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Miyahara, K. Odunsi, W. Chen, G. Peng, J. Matsuzaki, and R.-F. Wang
Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer
PNAS,
October 7, 2008;
105(40):
15505 - 15510.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Andersson, D. Q. Tran, M. Pesu, T. S. Davidson, H. Ramsey, J. J. O'Shea, and E. M. Shevach
CD4+FoxP3+ regulatory T cells confer infectious tolerance in a TGF-{beta}-dependent manner
J. Exp. Med.,
September 1, 2008;
205(9):
1975 - 1981.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kasprzycka, Q. Zhang, A. Witkiewicz, M. Marzec, M. Potoczek, X. Liu, H. Y. Wang, M. Milone, S. Basu, J. Mauger, et al.
{gamma}c-Signaling Cytokines Induce a Regulatory T Cell Phenotype in Malignant CD4+ T Lymphocytes
J. Immunol.,
August 15, 2008;
181(4):
2506 - 2512.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Kavanagh, S. O'Brien, D. Lee, Y. Hou, V. Weinberg, B. Rini, J. P. Allison, E. J. Small, and L. Fong
CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashion
Blood,
August 15, 2008;
112(4):
1175 - 1183.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Brinster and E. M. Shevach
Costimulatory effects of IL-1 on the expansion/differentiation of CD4+CD25+Foxp3+ and CD4+CD25+Foxp3- T cells
J. Leukoc. Biol.,
August 1, 2008;
84(2):
480 - 487.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Fragale, L. Gabriele, E. Stellacci, P. Borghi, E. Perrotti, R. Ilari, A. Lanciotti, A. L. Remoli, M. Venditti, F. Belardelli, et al.
IFN Regulatory Factor-1 Negatively Regulates CD4+CD25+ Regulatory T Cell Differentiation by Repressing Foxp3 Expression
J. Immunol.,
August 1, 2008;
181(3):
1673 - 1682.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zheng, C. N. Manzotti, F. Burke, L. Dussably, O. Qureshi, L. S. K. Walker, and D. M. Sansom
Acquisition of Suppressive Function by Activated Human CD4+CD25- T Cells Is Associated with the Expression of CTLA-4 Not FoxP3
J. Immunol.,
August 1, 2008;
181(3):
1683 - 1691.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. D. L. Savage, T. de Boer, K. V. Walburg, S. A. Joosten, K. van Meijgaarden, A. Geluk, and T. H. M. Ottenhoff
Human Anti-Inflammatory Macrophages Induce Foxp3+GITR+CD25+ Regulatory T Cells, Which Suppress via Membrane-Bound TGF{beta}-1
J. Immunol.,
August 1, 2008;
181(3):
2220 - 2226.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nagar, H. Vernitsky, Y. Cohen, D. Dominissini, Y. Berkun, G. Rechavi, N. Amariglio, and I. Goldstein
Epigenetic inheritance of DNA methylation limits activation-induced expression of FOXP3 in conventional human CD25-CD4+ T cells
Int. Immunol.,
August 1, 2008;
20(8):
1041 - 1055.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I Heier, K Malmstrom, A S Pelkonen, L P Malmberg, M Kajosaari, M Turpeinen, H Lindahl, P Brandtzaeg, F L Jahnsen, and M J Makela
Bronchial response pattern of antigen presenting cells and regulatory T cells in children less than 2 years of age
Thorax,
August 1, 2008;
63(8):
703 - 709.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y L Woo, J Sterling, R Crawford, S H van der Burg, N Coleman, and M Stanley
FOXP3 immunohistochemistry on formalin-fixed paraffin-embedded tissue: poor correlation between different antibodies
J. Clin. Pathol.,
August 1, 2008;
61(8):
969 - 971.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. S. Yolcu, X. Gu, C. Lacelle, H. Zhao, L. Bandura-Morgan, N. Askenasy, and H. Shirwan
Induction of Tolerance to Cardiac Allografts Using Donor Splenocytes Engineered to Display on Their Surface an Exogenous Fas Ligand Protein
J. Immunol.,
July 15, 2008;
181(2):
931 - 939.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Scotta, M. Soligo, C. Camperio, and E. Piccolella
FOXP3 Induced by CD28/B7 Interaction Regulates CD25 and Anergic Phenotype in Human CD4+CD25- T Lymphocytes
J. Immunol.,
July 15, 2008;
181(2):
1025 - 1033.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Serra, S. Nuti, S. Tavarini, C. Sammicheli, D. Rosa, G. Saletti, E. Soldaini, S. Abrignani, and A. Wack
Coligation of the Hepatitis C Virus Receptor CD81 with CD28 Primes Naive T Lymphocytes to Acquire Type 2 Effector Function
J. Immunol.,
July 1, 2008;
181(1):
174 - 185.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Liu and C. Rohowsky-Kochan
Regulation of IL-17 in Human CCR6+ Effector Memory T Cells
J. Immunol.,
June 15, 2008;
180(12):
7948 - 7957.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Grant, U. Oh, K. Yao, Y. Yamano, and S. Jacobson
Dysregulation of TGF-{beta} signaling and regulatory and effector T-cell function in virus-induced neuroinflammatory disease
Blood,
June 15, 2008;
111(12):
5601 - 5609.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sauer, L. Bruno, A. Hertweck, D. Finlay, M. Leleu, M. Spivakov, Z. A. Knight, B. S. Cobb, D. Cantrell, E. O'Connor, et al.
T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR
PNAS,
June 3, 2008;
105(22):
7797 - 7802.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. C. Fox, P. A. Bignone, P. J. Brown, and A. H. Banham
Defense of the clone: antibody 259D effectively labels human FOXP3 in a variety of applications
Blood,
April 1, 2008;
111(7):
3897 - 3899.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Passerini, S. E. Allan, M. Battaglia, S. Di Nunzio, A. N. Alstad, M. K. Levings, M. G. Roncarolo, and R. Bacchetta
STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25- effector T cells
Int. Immunol.,
March 1, 2008;
20(3):
421 - 431.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. C. Ndhlovu, C. P. Loo, G. Spotts, D. F. Nixon, and F. M. Hecht
FOXP3 expressing CD127lo CD4+ T cells inversely correlate with CD38+ CD8+ T cell activation levels in primary HIV-1 infection
J. Leukoc. Biol.,
February 1, 2008;
83(2):
254 - 262.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Das and A. D. Levine
TGF-{beta} Inhibits IL-2 Production and Promotes Cell Cycle Arrest in TCR-Activated Effector/Memory T Cells in the Presence of Sustained TCR Signal Transduction
J. Immunol.,
February 1, 2008;
180(3):
1490 - 1498.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Pillai and N. J. Karandikar
Attack on the clones? Human FOXP3 detection by PCH101, 236A/E7, 206D, and 259D reveals 259D as the outlier with lower sensitivity
Blood,
January 1, 2008;
111(1):
463 - 464.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Q. Tran and E. M. Shevach
Response: Anti human FOXP3 mAb PCH101 stains activated human naive T cells nonspecifically
Blood,
January 1, 2008;
111(1):
464 - 466.
[Full Text]
[PDF]
|
 |
|
|
|